TABLE OF CONTENTS
1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW OF THE ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET 25
1.4 LIMITATIONS 26
1.5 MARKETS COVERED 27
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 CURRENCY AND PRICING 31
2.5 DBMR TRIPOD DATA VALIDATION MODEL 32
2.6 MULTIVARIATE MODELLING 35
2.7 TYPE LIFELINE CURVE 35
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.9 DBMR MARKET POSITION GRID 37
2.10 MARKET END USER COVERAGE GRID 38
2.11 VENDOR SHARE ANALYSIS 39
2.12 SECONDARY SOURCES 40
2.13 ASSUMPTIONS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 44
4.1 PESTEL ANALYSIS 45
4.2 PORTERS FIVE FORCES MODEL 46
4.3 STRATEGIC INITIATIVES 47
5 ASIA PACIFIC DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 48
5.1 REGULATORY SCENARIO IN CHINA 48
5.2 REGULATORY SCENARIO IN AUSTRALIA 49
6 MARKET OVERVIEW 50
6.1 DRIVERS 52
6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 52
6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 52
6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 53
6.2 RESTRAINTS 54
6.2.1 STRINGENT REGULATIONS FOR APPROVAL 54
6.2.2 POSSIBLE RISK OF INFECTIONS 54
6.3 OPPORTUNITIES 55
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 55
6.3.2 INCREASING FOCUS ON INFECTION CONTROL 56
6.4 CHALLENGES 56
6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 56
6.4.2 LACK OF STANDARDIZATION 57
7 ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 58
7.1 OVERVIEW 59
7.2 SEMI-AUTOMATIC 62
7.3 AUTOMATIC 63
8 ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 64
8.1 OVERVIEW 65
8.2 BENCHTOP 68
8.2.1 SEMI-AUTOMATIC 69
8.2.2 AUTOMATIC 69
8.3 STANDALONE 69
8.3.1 SEMI-AUTOMATIC 70
8.3.2 AUTOMATIC 70
9 ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 71
9.1 OVERVIEW 72
9.2 DUAL STATION 75
9.3 SINGLE STATION 76
10 ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET, BY END USER 77
10.1 OVERVIEW 78
10.2 DIALYSIS CENTERS 81
10.3 HOSPITAL 82
10.4 HOME USE 83
11 ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET, BY REGION 84
11.1 ASIA-PACIFIC 85
11.1.1 CHINA 92
11.1.2 INDIA 94
11.1.3 AUSTRALIA 96
11.1.4 SINGAPORE 98
11.1.5 THAILAND 100
11.1.6 MALAYSIA 102
11.1.7 INDONESIA 104
11.1.8 PHILIPPINES 106
11.1.9 VIETNAM 108
11.1.10 REST OF ASIA-PACIFIC 110
12 ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 111
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 111
13 SWOT ANALYSIS 112
14 ASIA PACIFIC DIALYZER REPROCESSING MACHINES MARKET 113
14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 113
14.1.1 COMPANY SNAPSHOT 113
14.1.2 REVENUE ANALYSIS 113
14.1.3 COMPANY SHARE ANALYSIS 114
14.1.4 PRODUCT PORTFOLIO 114
14.1.5 RECENT DEVELOPMENTS 114
14.2 HEMANT SURGICAL INDUSTRIES LTD. 115
14.2.1 COMPANY SNAPSHOT 115
14.2.2 REVENUE ANALYSIS 115
14.2.3 COMPANY SHARE ANALYSIS 116
14.2.4 PRODUCT PORTFOLIO 116
14.2.5 RECENT DEVELOPMENTS 116
14.3 SAUBERN 117
14.3.1 COMPANY SNAPSHOT 117
14.3.2 COMPANY SHARE ANALYSIS 117
14.3.3 PRODUCT PORTFOLIO 118
14.3.4 RECENT DEVELOPMENTS 118
14.4 P.K. SCIENTIFIC & CHEMICALS 119
14.4.1 COMPANY SNAPSHOT 119
14.4.2 PRODUCT PORTFOLIO 119
14.4.3 RECENT DEVELOPMENT 119
14.5 LABSMED. 120
14.5.1 COMPANY SNAPSHOT 120
14.5.2 COMPANY SHARE ANALYSIS 120
14.5.3 PRODUCT PORTFOLIO 121
14.5.4 RECENT DEVELOPMENTS 121
14.6 ATLANTIC BIOMEDICAL 122
14.6.1 COMPANY SNAPSHOT 122
14.6.2 COMAPYN SHARE ANALYSIS 122
14.6.3 PRODUCT PORTFOLIO 123
14.6.4 RECENT DEVELOPMENT 123
14.7 ADVIN HEALTH CARE 124
14.7.1 COMPANY SNAPSHOT 124
14.7.2 PRODUCT PORTFOLIO 124
14.7.3 RECENT DEVELOPMENTS 124
14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 125
14.8.1 COMPANY SNAPSHOT 125
14.8.2 PRODUCT PORTFOLIO 125
14.8.3 RECENT DEVELOPMENT 125
14.9 CLINIVA HEALTHCARE 126
14.9.1 COMPANY SNAPSHOT 126
14.9.2 PRODUCT PORTFOLIO 126
14.9.3 RECENT DEVELOPMENT 126
14.10 GERYFALCON HEALTHCARE PVT. LTD. 127
14.10.1 COMPANY SNAPSHOT 127
14.10.2 PRODUCT PORTFOLIO 127
14.10.3 RECENT DEVELOPMENT 127
14.11 NANOTECH 128
14.11.1 COMPANY SNAPSHOT 128
14.11.2 PRODUCT PORTFOLIO 128
14.11.3 RECENT DEVELOPMENTS 128
14.12 WESLEY BIOTECH 129
14.12.1 COMPANY SNAPSHOT 129
14.12.2 PRODUCT PORTFOLIO 129
14.12.3 RECENT DEVELOPMENT 129
15 QUESTIONNAIRE 130
16 RELATED REPORTS 133

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.